This study aims to evaluate the clinical outcomes of endoscopic vein harvesting （EVH） for coronary artery bypass grafting （CABG） in obese patients. Totally, 153 obese patients who underwent EVH （n=81） or standar...This study aims to evaluate the clinical outcomes of endoscopic vein harvesting （EVH） for coronary artery bypass grafting （CABG） in obese patients. Totally, 153 obese patients who underwent EVH （n=81） or standard bridging technique （SBT, n=72） in CABG surgery from May 2012 to October 2014 in our hospital were enrolled in this retrospective non-randomized controlled study. The general situation of operation, postoperative complications and short medium-term outcomes were analyzed. The baseline characteristics were similar between these two groups （P〉0.05）. There were no statistical differences in total operation time （226±28 min vs. 224±30 min, P〉0.05）, number of damaged vessels （0.12±0.05 vs. 0.16±0.06, P〉0.05） and short medium-term outcomes including revascularization rate （1.25% vs. 2.78%, P〉0.05）, vessel dysfunction rate （11.25% vs. 11.11%, P〉0.05） and mortality （0.00% vs. 0.00%, P〉0.05）. Use of EVH was associated with significant reduction of total harvesting time （41±6 min vs. 63±11 min, P〈0.05）, incision length （4.4±1.1 cm vs. 18.2±4.5 cm, P〈0.05） and postoperative lower extremity complications （P〈0.05）. EVH can reduce the risk of wound complications, whereas does not influence short- and medium-term outcomes in obese patients. It can be considered a reliable procedure of harvesting vessel conduits for obese patients undergoing CABG.展开更多
Background Through a ministernotomy ＂J shaped approach, left internal mammary artery （LIMA） bypass grafting to the left anterior descending artery （LAD） can be performed safely off-pump. To achieve a complete rev...Background Through a ministernotomy ＂J shaped approach, left internal mammary artery （LIMA） bypass grafting to the left anterior descending artery （LAD） can be performed safely off-pump. To achieve a complete revascularization, percutaneous coronary interventions （PCI） with drug eluting stent implantation to other coronary arteries was used. We reported outcomes of the treatment of multivessel coronary artery disease with minimally invasive coronary artery bypass （MICAB） and PCI. Methods Between January 2009 and Dec 2012, 14 patients （11 males, 3 females, mean age was 64.8 _ 10.1 years. Two-vessel disease account for 35.7% （5/14） of these patients, three-vessel disease 64.2% （9/14） （Table 1）. All patients underwent a minimally invasive coronary artery bypass grafting via mini-sternotomy ＂J＂ shaped approach. Seven patients were followed by PCI, 7 for obtuse marginal circumflex, 5 for right coronary artery （RCA）. Angiographic assessment of graft patency was performed in all patients during the PCI procedure. The clinical follow-up period lasts from 11-24 months. Results The in-hospital mortality was 0%. There was neither conversion to a full median sternotomy nor intraoperative complications. Ventilation time was 6.6 ＋_ 4.1 h. Blood loss ranged 341 ＋_ 78.8 mL. ICU stay ranged 22.3 _ 12.8 h. Hospital postoperative stay lasted for 6.5 ＋ 1.6 days. Prior to PCI patients showed 100% patent left internal mammary artery. One patient had mediastinitis （Tables 2-3）. Rate of freedom from cardiac reintervention during the follow-up period was 92.8% （13/14）. Conclusions The inferior J-shaped sternotomy is simple, reproducible, and the safest technique for performing minimally invasive coronary bypass surgery. MICAB ＋ PCI is also safe, feasible and efficacious.展开更多
Background Hybrid coronary revascularization （HCR） is an altemative coronary revascularization strategy that combines a minimally invasive, survival advantage of the left internal mammary artery （LIMA） -left anter...Background Hybrid coronary revascularization （HCR） is an altemative coronary revascularization strategy that combines a minimally invasive, survival advantage of the left internal mammary artery （LIMA） -left anterior descending （LAD） coronary artery bypass with less-invasive percutaneous coronary intervention （PCI） to non-LAD coronary lesions by using drug-eluting stents. We report our experience of hybrid minimally invasive approach in 15 patients. Methods From December 2012 to October 2013, 15 patients underwent revascularization of the left anterior descending artery through minimally invasive coronary artery bypass grafting （MIDCAB）. All patients by endoscopic assist beating heart coronary artery bypass grafting. Seven patients were scheduled for a hybrid procedure. Percutaneous coronary intervention of non- LAD was performed 3 to 5 days preoperatively. Demographic data, perioperative outcome, and annual follow-up were obtained from all the patients. Results In-hospital mortality was 6.67%. The rate of conversion to full median sternotomy was 13.3%. Ventilation time was 6.9 ± 5.1 h. Blood loss volume was 241 ± 67.8 mL. ICU stay was 21.3 ± 10.8 h. Hospital postoperative stay lasted for 7.5 ± 1.3 days. Prior to PCI patients showed 100% patent LIMA （Tables 3 and 4）. A mean follow-up was 8.5 months. One year graft patency rate was 100% （8/8 patients for 254-slice tomography）. Two patients required reintervention. Conclusions Minimally invasive hybrid coronary revascularization is a safe, feasible and efficacious approach with good results and should be performed in selected patients by surgeons with experience in minimally invasive bypass surgery plus collaboration with cardiologists, eluting stents.展开更多
目的心脏手术患者液体治疗策略历来存有争论。文中旨在观察目标导向血流动力学管理策略对非体外循环冠状动脉搭桥手术患者预后的影响。方法选取安徽医科大学第一附属医院2016年1-12月择期行非体外循环冠状动脉搭桥术的98例患者纳入研究...目的心脏手术患者液体治疗策略历来存有争论。文中旨在观察目标导向血流动力学管理策略对非体外循环冠状动脉搭桥手术患者预后的影响。方法选取安徽医科大学第一附属医院2016年1-12月择期行非体外循环冠状动脉搭桥术的98例患者纳入研究。以2016年6月20日进行质量改进为截点。质量改进前56例患者纳入对照组、质量改进后42例患者纳入试验组。质量改进措施为采用以每博量变异和心脏指数为目标导向液体治疗输注液体,标准化使用血管活性药物,优化血流动力学。通过电子病历系统采集术中和术后数据,比较两组患者的液体出入量、术后住院天数和并发症、术后苏醒时间、24小时胸腔引流量、6小时内拔管率、ICU驻留时间、术后第1天肌钙蛋白I水平、30天病死率以及半年病死率。结果采用目标导向血流动力学管理后,试验组较对照组液体总入量差异无统计学意义,其中万汶输注量显著增加[(676.79±380.90)mL vs(890.48±222.58)mL]、晶体输注量显著减少[(663.84±224.97)mL vs(430.24±201.76)mL]、尿量显著增加[(516.07±224.87)mL vs(695.24±311.53)mL],液体正平衡显著减少[(683.82±556.08)mL vs(456.43±505.36)mL],差异均有统计学意义(P<0.05);自体血回输、红细胞输注比例、出血量两组间差异无统计学意义(P>0.05)。两组术后苏醒时间、24小时胸腔引流量、6小时内拔管率、术后第1天肌钙蛋白I水平、ICU驻留时间无统计学差异(P>0.05)。两组术后住院天数试验组较对照组显著减少(11.81 d vs 13.82 d,P<0.05)。对其对数转换后进行多元线性回归分析,得出质量改进措施的标准化系数B为-0.296(SE=0.061,P<0.05),说明其他条件相同时,采用目标导向血流动力学管理能减少术后住院天数19.4%(95%CI 7.3%～31.5%)。术后并发症从41.07%下降至16.67%,差异有统计学意义(P<0.05)。结论非体外循环冠状动脉搭桥术中采用目标导向血流动力学管理策略可有效降低术后并发症、减少术后住院天数,改善患者短期预后。展开更多
文摘This study aims to evaluate the clinical outcomes of endoscopic vein harvesting （EVH） for coronary artery bypass grafting （CABG） in obese patients. Totally, 153 obese patients who underwent EVH （n=81） or standard bridging technique （SBT, n=72） in CABG surgery from May 2012 to October 2014 in our hospital were enrolled in this retrospective non-randomized controlled study. The general situation of operation, postoperative complications and short medium-term outcomes were analyzed. The baseline characteristics were similar between these two groups （P〉0.05）. There were no statistical differences in total operation time （226±28 min vs. 224±30 min, P〉0.05）, number of damaged vessels （0.12±0.05 vs. 0.16±0.06, P〉0.05） and short medium-term outcomes including revascularization rate （1.25% vs. 2.78%, P〉0.05）, vessel dysfunction rate （11.25% vs. 11.11%, P〉0.05） and mortality （0.00% vs. 0.00%, P〉0.05）. Use of EVH was associated with significant reduction of total harvesting time （41±6 min vs. 63±11 min, P〈0.05）, incision length （4.4±1.1 cm vs. 18.2±4.5 cm, P〈0.05） and postoperative lower extremity complications （P〈0.05）. EVH can reduce the risk of wound complications, whereas does not influence short- and medium-term outcomes in obese patients. It can be considered a reliable procedure of harvesting vessel conduits for obese patients undergoing CABG.
文摘Background Through a ministernotomy ＂J shaped approach, left internal mammary artery （LIMA） bypass grafting to the left anterior descending artery （LAD） can be performed safely off-pump. To achieve a complete revascularization, percutaneous coronary interventions （PCI） with drug eluting stent implantation to other coronary arteries was used. We reported outcomes of the treatment of multivessel coronary artery disease with minimally invasive coronary artery bypass （MICAB） and PCI. Methods Between January 2009 and Dec 2012, 14 patients （11 males, 3 females, mean age was 64.8 _ 10.1 years. Two-vessel disease account for 35.7% （5/14） of these patients, three-vessel disease 64.2% （9/14） （Table 1）. All patients underwent a minimally invasive coronary artery bypass grafting via mini-sternotomy ＂J＂ shaped approach. Seven patients were followed by PCI, 7 for obtuse marginal circumflex, 5 for right coronary artery （RCA）. Angiographic assessment of graft patency was performed in all patients during the PCI procedure. The clinical follow-up period lasts from 11-24 months. Results The in-hospital mortality was 0%. There was neither conversion to a full median sternotomy nor intraoperative complications. Ventilation time was 6.6 ＋_ 4.1 h. Blood loss ranged 341 ＋_ 78.8 mL. ICU stay ranged 22.3 _ 12.8 h. Hospital postoperative stay lasted for 6.5 ＋ 1.6 days. Prior to PCI patients showed 100% patent left internal mammary artery. One patient had mediastinitis （Tables 2-3）. Rate of freedom from cardiac reintervention during the follow-up period was 92.8% （13/14）. Conclusions The inferior J-shaped sternotomy is simple, reproducible, and the safest technique for performing minimally invasive coronary bypass surgery. MICAB ＋ PCI is also safe, feasible and efficacious.
文摘Background Hybrid coronary revascularization （HCR） is an altemative coronary revascularization strategy that combines a minimally invasive, survival advantage of the left internal mammary artery （LIMA） -left anterior descending （LAD） coronary artery bypass with less-invasive percutaneous coronary intervention （PCI） to non-LAD coronary lesions by using drug-eluting stents. We report our experience of hybrid minimally invasive approach in 15 patients. Methods From December 2012 to October 2013, 15 patients underwent revascularization of the left anterior descending artery through minimally invasive coronary artery bypass grafting （MIDCAB）. All patients by endoscopic assist beating heart coronary artery bypass grafting. Seven patients were scheduled for a hybrid procedure. Percutaneous coronary intervention of non- LAD was performed 3 to 5 days preoperatively. Demographic data, perioperative outcome, and annual follow-up were obtained from all the patients. Results In-hospital mortality was 6.67%. The rate of conversion to full median sternotomy was 13.3%. Ventilation time was 6.9 ± 5.1 h. Blood loss volume was 241 ± 67.8 mL. ICU stay was 21.3 ± 10.8 h. Hospital postoperative stay lasted for 7.5 ± 1.3 days. Prior to PCI patients showed 100% patent LIMA （Tables 3 and 4）. A mean follow-up was 8.5 months. One year graft patency rate was 100% （8/8 patients for 254-slice tomography）. Two patients required reintervention. Conclusions Minimally invasive hybrid coronary revascularization is a safe, feasible and efficacious approach with good results and should be performed in selected patients by surgeons with experience in minimally invasive bypass surgery plus collaboration with cardiologists, eluting stents.
文摘目的心脏手术患者液体治疗策略历来存有争论。文中旨在观察目标导向血流动力学管理策略对非体外循环冠状动脉搭桥手术患者预后的影响。方法选取安徽医科大学第一附属医院2016年1-12月择期行非体外循环冠状动脉搭桥术的98例患者纳入研究。以2016年6月20日进行质量改进为截点。质量改进前56例患者纳入对照组、质量改进后42例患者纳入试验组。质量改进措施为采用以每博量变异和心脏指数为目标导向液体治疗输注液体,标准化使用血管活性药物,优化血流动力学。通过电子病历系统采集术中和术后数据,比较两组患者的液体出入量、术后住院天数和并发症、术后苏醒时间、24小时胸腔引流量、6小时内拔管率、ICU驻留时间、术后第1天肌钙蛋白I水平、30天病死率以及半年病死率。结果采用目标导向血流动力学管理后,试验组较对照组液体总入量差异无统计学意义,其中万汶输注量显著增加[(676.79±380.90)mL vs(890.48±222.58)mL]、晶体输注量显著减少[(663.84±224.97)mL vs(430.24±201.76)mL]、尿量显著增加[(516.07±224.87)mL vs(695.24±311.53)mL],液体正平衡显著减少[(683.82±556.08)mL vs(456.43±505.36)mL],差异均有统计学意义(P<0.05);自体血回输、红细胞输注比例、出血量两组间差异无统计学意义(P>0.05)。两组术后苏醒时间、24小时胸腔引流量、6小时内拔管率、术后第1天肌钙蛋白I水平、ICU驻留时间无统计学差异(P>0.05)。两组术后住院天数试验组较对照组显著减少(11.81 d vs 13.82 d,P<0.05)。对其对数转换后进行多元线性回归分析,得出质量改进措施的标准化系数B为-0.296(SE=0.061,P<0.05),说明其他条件相同时,采用目标导向血流动力学管理能减少术后住院天数19.4%(95%CI 7.3%～31.5%)。术后并发症从41.07%下降至16.67%,差异有统计学意义(P<0.05)。结论非体外循环冠状动脉搭桥术中采用目标导向血流动力学管理策略可有效降低术后并发症、减少术后住院天数,改善患者短期预后。
